Cerebras looks attractive because the short report's two-year wafer-life thesis rests on unvalidated reliability assumptions, not representative failure data. Energy per useful token, lower warranty utilization and ordinary repair accounting also undercut its financial conclusions. OpenAI has integrated Cerebras into production; AMD and AWS have announced integrations, while Oracle plans 2027 availability for ultra-fast inference, adding commercial validation despite the report. x.com  x.com 

Cerebras may be the only company willing to stitch together a true high-speed solution. If so, it retains upside optionality from high-speed pricing and gains a first-mover advantage. x.com  x.com 

Cerebras is difficult for retail investors to understand, and management has not done a great job explaining its business since going public. It deserves more attention as the most direct AI IPO of 2026, but going long Cerebras is hard to justify when Nvidia can be owned instead. x.com 

Cerebras is a speculative, high-risk, high-reward bet on faster inference that could make its $44B market cap a multi-bagger if it works. Putting the whole processor and memory on one wafer wins on speed, not cheaper memory, since on-chip SRAM costs more per bit than HBM; Nvidia is answering via Groq. G42 and MBZUAI were 86% of 2025 revenue, but the ramp ahead is tied to OpenAI. The $160s level has held as support four times since the IPO. Size it to one's capital-preservation goals. x.com 

Cerebras and its customers likely accounted for many of the chip limitations alleged in the short report, so the report may be wrong. This is a suspicion without specific insight. Short interest rose 40.7% into the report to 19.86 million shares, or 8.4% of float. x.com  x.com 

Cerebras's share price already assumes years of flawless execution, so investors can be right about the company long term and still lose money. Two customers make up 86% of revenue, it posted a $146 million operating loss in 2025, its GAAP profit came from accounting gains, and it trades at 111x revenue. The wafer-scale technology, 15x faster AI inference and $20B+ OpenAI compute deal make the bull case real, but the price leaves no margin for early-stage setbacks. x.com 

Nvidia's cash could have more value invested in AI companies with strong demand but too little capital to scale, especially neoclouds that can execute. Their valuations look very attractive now, making equity stakes preferable to more buybacks or dividends despite criticism of circular deals. SpaceX may need the money less because it is already very big. x.com  x.com  x.com 

Cerebras' inference opportunity can support substantial long-term upside if installed capacity grows from 60MW to 3.2GW by 2031 and OpenAI renews after 2028. The risk-adjusted model puts 2031 value at $485-$700 per share while assuming rivals narrow its speed premium and customers and partners fund most capex. If those assumptions fail, capex, dilution and valuation risk rise. x.com 

Cerebras fits the pattern of many recent IPOs: a low float plus retail FOMO produces a high valuation that then bleeds down over months. As @aleabitoreddit puts it, it is a good company but hard to like at a ~$90-100 billion market cap, and float dynamics could keep it at absurd valuations for a short time before things correct. x.com 

Nvidia's CUDA retains developers, putting it among 12 stocks that could dominate the decade ahead. Nebius's GPU rental price rise signals demand; Fabrinet and Credo supply AI connectivity. DraftKings has betting scale; Microsoft has Azure and an OpenAI partnership; Figma anchors design work; Shopify powers stores. TeraWulf pivots power sites to AI leases; Constellation, the largest US nuclear operator, signs big-tech power deals; Meta spends on AI; Uber has autonomous-vehicle partnerships. x.com  … Show more